Problems with Current Pharmacologic Treatment of Parkinson's Disease

Author： Hurtig H.I.  

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.144, Iss.1, 1997-03, pp. : 10-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parkinson's Disease: The Treatment Options.

By Bain P.G.  

Brain, Vol. 123, Iss. 3, 2000-03 ,pp. : 651-652

Oxford University Press

Access to resources Recommend Favorite

Neural transplantation for the treatment of Parkinson's disease

By Bjorklund A.   Dunnett S.B.   Brundin P.   Stoessl A.J.   Freed C.R.   Breeze R.E.   Levivier M.   Peschanski M.   Studer L.   Barker R.  

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

The potential of GDNF as a treatment for Parkinson's disease

By Hurelbrink C.B.   Barker R.A.  

Experimental Neurology, Vol. 185, Iss. 1, 2004-01 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

New treatment of depression in Parkinson's disease

By Maruyama Tetsuhiro  

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 25-27

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Network modulation in the treatment of Parkinson's disease

By Asanuma Kotaro   Tang Chengke   Ma Yilong   Dhawan Vijay   Mattis Paul   Edwards Christine   Kaplitt Michael G.   Feigin Andrew   Eidelberg David  

Brain, Vol. 129, Iss. 10, 2006-10 ,pp. : 2667-2678

Oxford University Press

Access to resources Recommend Favorite